Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -233.39%-91.48M | ---- | -66.52%68.58M | ---- | -14.01%204.86M | ---- | 99.99%238.24M | ---- | -45.21%119.13M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -5.43%-13.9M | ---- | -128.21%-13.18M | ---- | -305.26%-5.78M | ---- | 39.82%-1.43M | ---- | 72.96%-2.37M |
| Attributable subsidiary (profit) loss | ---- | 55.56%-148K | ---- | -1,287.50%-333K | ---- | 98.01%-24K | ---- | 18.58%-1.21M | ---- | -46.10%-1.48M |
| Impairment and provisions: | ---- | 166.54%70.99M | ---- | -32.83%26.63M | ---- | -45.59%39.65M | ---- | -17.71%72.87M | ---- | 90.19%88.55M |
| -Impairment of property, plant and equipment (reversal) | ---- | 1,118.43%33.49M | ---- | -114.62%-3.29M | ---- | 907.25%22.49M | ---- | ---2.79M | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | -11.88%29.19M | ---- | 103.85%33.12M | ---- | -72.77%16.25M | ---- | -19.54%59.68M | ---- | 267.26%74.17M |
| -Impairment of trade receivables (reversal) | ---- | 702.93%5.48M | ---- | -96.65%683K | ---- | 597.91%20.41M | ---- | -79.67%2.92M | ---- | 967.06%14.38M |
| -Other impairments and provisions | ---- | 172.77%2.83M | ---- | 80.07%-3.89M | ---- | -249.30%-19.5M | ---- | --13.06M | ---- | ---- |
| Revaluation surplus: | ---- | 414.67%100.2M | ---- | 32.59%-31.84M | ---- | 32.86%-47.24M | ---- | 40.82%-70.36M | ---- | 5.21%-118.9M |
| -Fair value of investment properties (increase) | ---- | 428.04%105.6M | ---- | 31.09%-32.19M | ---- | 34.58%-46.72M | ---- | 41.86%-71.41M | ---- | -2.02%-122.82M |
| -Other fair value changes | ---- | -1,651.44%-5.4M | ---- | 166.67%348K | ---- | -149.95%-522K | ---- | -73.36%1.05M | ---- | 177.65%3.92M |
| Asset sale loss (gain): | ---- | -114.20%-202.7M | ---- | -83.71%-94.63M | ---- | -6,842.28%-51.51M | ---- | -57.60%764K | ---- | 267.94%1.8M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -226.07%-28.72M | ---- | -2,836.00%-8.81M | ---- | -139.27%-300K | ---- | -57.60%764K | ---- | 267.94%1.8M |
| -Loss (gain) from selling other assets | ---- | -102.72%-173.98M | ---- | -67.59%-85.82M | ---- | ---51.21M | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | 4.88%245.16M | ---- | 1.22%233.74M | ---- | -6.47%230.91M | ---- | 12.03%246.88M | ---- | 7.81%220.37M |
| -Depreciation | ---- | 4.96%242.65M | ---- | 1.51%231.19M | ---- | -4.83%227.75M | ---- | 12.22%239.29M | ---- | 8.04%213.24M |
| -Amortization of intangible assets | ---- | -1.61%2.51M | ---- | -19.55%2.55M | ---- | -58.29%3.17M | ---- | 6.48%7.59M | ---- | 1.11%7.13M |
| Financial expense | ---- | 4.58%337.18M | ---- | 97.70%322.43M | ---- | 66.72%163.09M | ---- | -24.01%97.82M | ---- | -18.98%128.73M |
| Special items | ---- | -79,369.81%-42.12M | ---- | 94.56%-53K | ---- | ---974K | ---- | ---- | ---- | -276.39%-9.39M |
| Operating profit before the change of operating capital | ---- | -21.15%403.19M | ---- | -4.06%511.34M | ---- | -8.67%533M | ---- | 36.85%583.59M | ---- | -12.71%426.43M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -193.09%-50.83M | ---- | 157.12%54.6M | ---- | -688.66%-95.59M | ---- | 108.70%16.24M | ---- | -161,009.48%-186.66M |
| Accounts receivable (increase)decrease | ---- | -268.95%-86.9M | ---- | 127.14%51.43M | ---- | -61.50%-189.54M | ---- | -146.73%-117.36M | ---- | 164.67%251.17M |
| Accounts payable increase (decrease) | ---- | 388.77%105.28M | ---- | -122.23%-36.46M | ---- | 505.25%164.01M | ---- | -143.88%-40.47M | ---- | 194.67%92.23M |
| Cash from business operations | ---- | -36.18%370.75M | ---- | 41.04%580.92M | ---- | -6.81%411.88M | ---- | -24.21%442M | ---- | 19.97%583.17M |
| Other taxs | ---- | 74.20%-17.22M | ---- | -38.40%-66.73M | ---- | -161.73%-48.22M | ---- | 64.72%-18.42M | ---- | 51.18%-52.22M |
| Special items of business | -104.17%-6.06M | ---- | 80.63%145.4M | ---- | -62.39%80.5M | ---- | 623.87%214.02M | ---- | -76.49%29.57M | ---- |
| Net cash from operations | -104.17%-6.06M | -31.24%353.53M | 80.63%145.4M | 41.39%514.18M | -62.39%80.5M | -14.15%363.66M | 623.87%214.02M | -20.22%423.58M | -76.49%29.57M | 40.04%530.96M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 5.76%13.95M | ---- | 130.65%13.19M | ---- | 300.91%5.72M | ---- | -42.50%1.43M | ---- | -71.69%2.48M |
| Dividend received - investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 129.15%1.59M | ---- | -73.93%693K |
| Loan receivable (increase) decrease | ---- | ---128.7M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | ---- | 143.52%80.87M | ---- | 34.66%33.21M | ---- | 2,067.14%24.66M | ---- | -4.85%1.14M | ---- | -27.91%1.2M |
| Purchase of fixed assets | ---- | 31.68%-196.53M | ---- | -33.17%-287.68M | ---- | 0.09%-216.02M | ---- | 35.55%-216.2M | ---- | -104.58%-335.44M |
| Selling intangible assets | ---- | 51.19%197.36M | ---- | 367.94%130.53M | ---- | --27.9M | ---- | ---- | ---- | ---- |
| Purchase of intangible assets | ---- | 29.17%-2.94M | ---- | -336.13%-4.15M | ---- | 8.99%-952K | ---- | 97.64%-1.05M | ---- | -31.30%-44.4M |
| Recovery of cash from investments | ---- | ---- | ---- | -66.27%75.3M | ---- | --223.22M | ---- | ---- | ---- | ---- |
| Cash on investment | ---- | -113.87%-60.65M | ---- | 67.27%-28.36M | ---- | -93.45%-86.64M | ---- | 45.28%-44.79M | ---- | -18.25%-81.85M |
| Other items in the investment business | 119.22%18.41M | ---- | -484.81%-95.76M | ---- | 74.06%-16.38M | ---- | 52.17%-63.12M | ---- | 44.80%-131.96M | ---- |
| Net cash from investment operations | 119.22%18.41M | -42.21%-96.65M | -484.81%-95.76M | -207.25%-67.96M | 74.06%-16.38M | 91.42%-22.12M | 52.17%-63.12M | 43.61%-257.88M | 44.80%-131.96M | -80.10%-457.31M |
| Net cash before financing | -75.13%12.35M | -42.43%256.89M | -22.59%49.64M | 30.65%446.22M | -57.51%64.12M | 106.13%341.54M | 247.36%150.9M | 124.99%165.69M | 9.62%-102.4M | -41.19%73.64M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | -57.16%1.37B | ---- | 160.45%3.19B | ---- | 6.43%1.22B | ---- | -73.66%1.15B | ---- | 256.69%4.37B |
| Refund | ---- | 59.32%-1.3B | ---- | -127.11%-3.2B | ---- | -27.91%-1.41B | ---- | 71.78%-1.1B | ---- | -321.85%-3.9B |
| Interest paid - financing | ---- | -4.54%-335.47M | ---- | -96.86%-320.89M | ---- | -66.16%-163M | ---- | 24.18%-98.1M | ---- | 18.68%-129.37M |
| Dividends paid - financing | ---- | ---- | ---- | 20.00%-76.89M | ---- | 0.00%-96.11M | ---- | 0.00%-96.11M | ---- | 12.34%-96.11M |
| Other items of the financing business | 233.22%207.09M | ---- | 41.39%-155.45M | ---- | -43.78%-265.23M | ---- | -0.31%-184.47M | ---- | -995.66%-183.9M | 96.84%-4.78M |
| Net cash from financing operations | 233.22%207.09M | 28.45%-341.98M | 41.39%-155.45M | 7.25%-477.95M | -43.78%-265.23M | -134.16%-515.34M | -0.31%-184.47M | -230.42%-220.08M | -995.66%-183.9M | 187.79%168.74M |
| Effect of rate | 290.12%17.71M | -713.35%-25.26M | -462.51%-9.31M | 116.43%4.12M | 125.33%2.57M | -81.55%-25.07M | -3,330.57%-10.14M | -168.66%-13.81M | 104.30%314K | 303.37%20.11M |
| Net Cash | 307.39%219.43M | -168.13%-85.09M | 47.39%-105.81M | 81.74%-31.73M | -499.05%-201.11M | -219.54%-173.8M | 88.27%-33.57M | -122.44%-54.39M | -208.64%-286.29M | 461.87%242.39M |
| Begining period cash | -16.61%553.97M | -3.99%664.32M | -3.99%664.32M | -22.32%691.93M | -22.32%691.93M | -7.11%890.8M | -7.11%890.8M | 37.69%959M | 37.69%959M | -9.94%696.5M |
| Cash at the end | 44.05%791.11M | -16.61%553.97M | 11.31%549.2M | -3.99%664.32M | -41.75%493.4M | -22.32%691.93M | 25.86%847.09M | -7.11%890.8M | 12.84%673.02M | 37.69%959M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Touche Tohmatsu | -- | Deloitte Touche Tohmatsu | -- | Deloitte Touche Tohmatsu | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.